DDrare: Database of Drug Development for Rare Diseases

Everolimus oral product (DrugBank: Everolimus)

2 diseases

ID	Disease name (Link within this page)	Number of trials
89	Lymphangioleiomyomatosis	1
158	Tuberous sclerosis	1

89. Lymphangioleiomyomatosis [ 38 clinical trials, 42 drugs, (DrugBank: 19 drugs), 26 drug target genes, 134 drug target pathways]

Searched query = "Lymphangioleiomyomatosis", "LAM"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 38 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02061397 (ClinicalTrials.gov)	March 2014	23/1/2014	Safety of Simvastatin in LAM and TSC	The Safety of Simvastatin (SOS) in Patients With Pulmonary Lymphangioleiomyomatosis (LAM) and With Tuberous Sclerosis Complex (TSC)	Lymphangioleiomyomatosis;Tuberous Sclerosis Complex	Drug: Simvastatin;Drug: Sirolimus Oral Product;Drug: Everolimus Oral Product	University of Pennsylvania	The LAM Foundation	Completed	18 Years	N/A	Female	10	Phase 1;Phase 2	United States

158. Tuberous sclerosis [ 100 clinical trials, 62 drugs, (DrugBank: 16 drugs), 35 drug target genes, 115 drug target pathways]

Searched query = "Tuberous sclerosis", "Tuberous sclerosis complex"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 100 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02061397 (ClinicalTrials.gov)	March 2014	23/1/2014	Safety of Simvastatin in LAM and TSC	The Safety of Simvastatin (SOS) in Patients With Pulmonary Lymphangioleiomyomatosis (LAM) and With Tuberous Sclerosis Complex (TSC)	Lymphangioleiomyomatosis;Tuberous Sclerosis Complex	Drug: Simvastatin;Drug: Sirolimus Oral Product;Drug: Everolimus Oral Product	University of Pennsylvania	The LAM Foundation	Completed	18 Years	N/A	Female	10	Phase 1;Phase 2	United States